A novel 5'ALK fusion identified by next generation sequencing and validated by IHC in a patient with lung adenocarcinoma

Lung Cancer. 2021 Aug:158:164-165. doi: 10.1016/j.lungcan.2021.06.006. Epub 2021 Jun 8.

Authors

Zhengfu He¹, Xingyu Zhu¹, Qingxin Zeng¹, Zhaonan Yu²

Affiliations

¹ Department of Thoracic Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang Province, China.
² Hangzhou D.A. Medical Laboratory, Hangzhou, 310030, China. Electronic address: yuzhaonan870213@163.com.

PMID: 34120772
DOI: 10.1016/j.lungcan.2021.06.006

No abstract available

Publication types

Letter

MeSH terms

Adenocarcinoma of Lung* / diagnosis
Adenocarcinoma of Lung* / genetics
Anaplastic Lymphoma Kinase / genetics
High-Throughput Nucleotide Sequencing
Humans
Lung Neoplasms* / diagnosis
Lung Neoplasms* / genetics
Oncogene Proteins, Fusion / genetics

Substances

Oncogene Proteins, Fusion
Anaplastic Lymphoma Kinase